Shawn Levy

Shawn Levy

Auto-generated profile, based on publicly available information

Shawn Levy

HudsonAlpha Institute for Biotechnology

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2016 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SDSayantan Das
Sayantan Das
LFLukas Forer
Lukas Forer
SSSebastian Schönherr
Sebastian Schönherr
CSCarlo Sidore
Carlo Sidore
ALAdam E Locke
Adam E Locke
CFChristian Fuchsberger
Christian Fuchsberger

1 September 2006 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
MCMAQC Consortium
MAQC Consortium
LSLeming Shi
Leming Shi
LRLaura H Reid
Laura H Reid
Wendell JonesWendell Jones
Wendell Jones
RSRichard Shippy
Richard Shippy
WSWilliam Slikker
William Slikker
Over the last decade, the introduction of microarray technology has had a profound impact on gene expression research. The publication of studies with dissimilar or altogether contradictory results, obtained using different microarray platforms to analyze identical RNA samples, has raised concerns about the reliability of this technology. The MicroArray Quality Control (MAQC) project was initiated to address these concerns, as well as other performance and data analysis issues. Expression data on four titration pools from two distinct reference RNA samples were generated at multiple test sites using a variety of microarray-based and alternative technology platforms. Here we describe the experimental design and probe mapping efforts behind the MAQC project. We show intraplatform consistency across test sites as well as a high level of interplatform concordance in terms of genes identified as differentially expressed. This study provides a resource that represents an important first step toward establishing a framework for the use of microarrays in clinical and regulatory settings.

27 March 2015 in Science
Verified
Journal Article
Closed access
ECElizabeth T. Cirulli
Elizabeth T. Cirulli
BLBrittany Lasseigne
Brittany Lasseigne
SPSlavé Petrovski
Slavé Petrovski
PSPeter C. Sapp
Peter C. Sapp
PDPatrick A. Dion
Patrick A. Dion
DGDavid B. Goldstein
David B. Goldstein
New players in Lou Gehrig's disease: Amyotrophic lateral sclerosis (ALS), often referred to as “Lou Gehrig's disease,” is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Cirulli et al. sequenced the expressed genes of nearly 3000 ALS patients and compared them with those of more than 6000 controls (see the Perspective by Singleton and Traynor). They identified several proteins that were linked to disease in patients. One such protein, TBK1, is implicated in innate immunity and autophagy and may represent a therapeutic target. Science , this issue p. 1436 ; see also p. 1422

29 January 2004 in Nature
Verified
Journal Article
Closed access
PDF file
JKJason E. Kokoszka
Jason E. Kokoszka
KWKatrina G. Waymire
Katrina G. Waymire
SLShawn E. Levy
Shawn E. Levy
JSJames E. Sligh
James E. Sligh
JCJiyang Cai
Jiyang Cai
DWDouglas C C. Wallace
Douglas C C. Wallace

1 March 2010 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
JSJ. Joshua Smith
J. Joshua Smith
NDNatasha G. Deane
Natasha G. Deane
FWFei Wu
Fei Wu
NMNipun B. Merchant
Nipun B. Merchant
BZBing Zhang
Bing Zhang
RBR. Daniel Beauchamp
R. Daniel Beauchamp

30 May 2008 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
BXBin Xu
Bin Xu
JRJ Louw Roos
J Louw Roos
SLShawn Levy
Shawn Levy
ERE J van Rensburg
E J van Rensburg
JGJoseph A Gogos
Joseph A Gogos
MKMaria Karayiorgou
Maria Karayiorgou